Home / SearchSearch All Clinical Trials Treatments Resource Library Lymphoma Coalition Content Browse information on lymphoma diagnosis, treatment & survivorship Find clinical trial availability by country, therapy & lymphoma subtype Find treatments by therapy name, country & lymphoma subtype Over 4,000 articles on scientific advances in research, treatments & patient care Subtype reports, patient surveys & campaigns CategoryBiosimilar TherapiesCancer-Related Brain FunctionCAR TherapiesClinical GuidelinesDiagnosticsLifestyleRegulatoryReimbursement and FundingResearchResourcesSurvivorshipSurvivorship/LifestyleTherapiesTherapies and Clinical TrialsCategory2022 Global Patient Survey ToolkitCutaneous LymphomaDiagnosticsEffects of LymphomaeverywhereLC UpdatesLifestylelymphomaMember NewsResearchResourcesScience & TechnologySubtypesTherapiesTherapies and Clinical Trials,ResearchSubtypeAdult T-cell (ATCL)American Journal of HematologyAnaplastic Large Cell (ALCL)Angioimmunoblastic T-cell (AITL)B-cellB-lymphoblastic (B-LL)Bone LymphomaBurkitt (BL)Burkitt's (BL)Central Nervous System (CNSL)Chronic Lymphoctyic Leukemia (CLL)Chronic Lymphocytic Leukemia (CLL)Cutaneous B-cel (CBCL)Cutaneous B-cell (CBCL)Cutaneous T-cell (CTCL)Diffuse Large B-cell (DLBCL)Double-Hit (DHL)Extranodal Natural Killer (ENKTL)Fluid Overload-Associated Large B-cell (FO-LBCL)Follicular (FL)Follicular Helper T-cell (FHT)Gray Zone (GZL)Hairy Cell (HCL)Hepatosplenic T-cell lymphoma (HSTL)HIV-Associated LymphomaHodgkin (HL)Intravascular Large B-cell (IVLBCL)Mantle Cell (MCL)Marginal Zone (MZL)Mucosa-Associated Lymphoid Tissue (MALT)Non-Hodgkin (NHL)Ocular Adnexal Mantle Cell (OA-MCL)Orbital (OL)Peripheral T-cell (PTCL)PlasmablasticPrimary Adrenal Lymphoma (PAL)Primary Breast Diffuse Large B-cell (PB-DLBCL)Primary Colorectal Lymphoma (PCL)Primary Cutaneous Aggressive Epidermotropic Cytotoxic CD8+ T-Cell Lymphoma (CD8+ PCAETL)Primary Cutaneous B-cell (CBCL)Primary Cutaneous Follicle Center(PCFCL)Primary Cutaneous Gamma-Delta T-cell (PCGD-TCL)Primary Effusion Lymphoma (PEL)Primary Gastrointestinal (GI)Primary Mediastinal B-cell (PMBCL)Primary Ocular Adnexal MALT (OAML)Primary Ovarian (POL)Primary Pancreatic (PPL)Primary Pulmonary (PPL)Primary Spinal Epidural (PSENHL)Primary Testicular (PTL)Primary Thyroid Lymphoma (PTL)Primary Vitreoretinal (PVRL)Primary Vitreoretinal Lymphoma (PVRL)Richter Transformation (RT)Subcutaneous panniculitis-like T-cell (SPTCL)T-cellT-cell Histiocyte-rich Large B-cell (THRLBCL)T-lymphoblastic (T-LL)Triple-Hit (THL)Waldenstrom (WM)Country/RegionAfricaArgentinaArmeniaAsiaAustraliaAustriaBelgiumBotswanaBrazilCanadaChileChinaColombiaCroatiaCzech RepublicCzechiaDenmarkEgyptEthiopiaEuropeEuropean UnionFinlandFranceFrench GuianaGermanyGreeceHong KongHugaryHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJapanJordanKenyaKoreaLatin AmericaLebanonMalawiMexicoNetherlandsNew ZealandNorwayPakistanPeruPolandPortugalRomaniaRussian FederationSaudi ArabiaScotlandSenegalSingaporeSlovakiaSouth AfricaSouth KoreaSpainSudanSwedenSwitzerlandSybTypeTaiwanTanzaniaThailandTurkeyUgandaUKUkraineUnited KingdomUnited States"car t080311q11q deletion13q deletion17p17p cll17p del17p deletion18f-fdg pet/ct1991p36 deletion1st1st line200020082012201420232nd2nd line3 hydroxybutyrate3d analysis5-azacitidine6q23 deletion7090y90y-ibritumomab-tiuxetana phase 2 studya phase iiaacr 2020aacr 2021aacr 2024abcabc-dlbclabdominabdominalabexinostataboriginalabsolute lymphocyteabsolute lymphocyte countabstractabt-199abt-199. resistanceabt-263abvdacalabrutinibacalabrutnibacalubrutinibaccelerated chronic lymphocytic leukemiaaccessaccupunctureacd4cacetaminophenacidacquired immune deficiency syndromeacquired immunodeficency syndromeacquired immunodeficiency syndromeactemraactivatedactivated b cellactivated b-cellactivated cellsactivationactivation induced cytidine deaminaseactivation related cheokineactive idiotypic vaccinationactive surveillanceactived b cellacupunctureacuteacute kidney injuryacute myeloidadavanced stageadcadcetrisaddictionadectrisadenocarcinomaadenosine diphosphateadenovirusadnexaadnexaladolescenceadolescentadolescentsadrenaladriamycinadsolescentadultadult t celladult t-celladvancedadvanced diffuse large b celladvanced stageadvere eventadverseadverse effectsadverse eventadverse event toxicityadverse event. toxicityadverse eventsadvese eventadvest eventsaethera trialafinitorafm13africaafrican americanaftafter treatmentafuresertibageage groupsaggressiveaggressive b cellaggressive lymphomaagmtagriculturalagricultureagvhdahctahsctaidsaids relatedaihaair pollutionairuikaaitlaktalbuminalclalcoholalecensaalectinibalemtuzumabalgorithmalgorithmsaliqopaalisertibalkalk gene rearrangementalk inhibitoralk negativealk positivealkylatingallergic reactionallergiesallergyalllogeneic car-talloallo hctallo sctallo-501aallo-647allo-sctallo-sct car-tallogeneicallogeneic car-tallogeneic hctallogeneic hematopoieticallogeneic hematopoietic stem cell transplantallogeneic stem cellallogeneic stem cell transplantallogeneic stem cell transplantationallogeneiceallogeneice stem cell transplantallogeneticallogenicallogenneicallohctallosctalterationsamericaamino acidamlamulirafusp alfaanaemiaanakinraanalanalysisanaphylactic shockanaplastc large cellanaplasticanaplastic large cellanaplastic large t-cellanaplastic lymphoma kinaseanaplastic lymphoma kinaseâpositiveanaplastic variantanbal-celanbalcabtagene autoleucelanemiaanergic signatureangiogenesisangioimmunoblasticangioimmunoblastic t-cellanitbioticanplastic large cellantagonistantenatalanthracyclineanthracyclinesantianti cd19anti cd20anti pd1anti tnfanti tumoranti-ccr4anti-cd19anti-cd20anti-cd20 monoclonal antibodyanti-tumour necrosis factorantibioticantibioticsantibodiesantibodyantibody drug conjugateantibody drug conjugatesantibody drug conjugatgeantibody responseantibody-drug conjugatesanticanceranticoagulationantigen receptorantineoplasticantinuclear antibodiesantioxidantantiplateletantipsychoticantiretroviralantitumorantitumourantiviralantiviral therapyantivrialanusanxietyapatinibapg-2575apixabanaplastic anemiaapolipoprotein a1apoptosisappendicitisappetiteaquired immunodeficiency syndromeara-carbovirusargentinaari-0001armeniaarrhythmiaarrhythmiasarsenicartarterialarthralgiaarticlearticle from the international conference of malignant lymphomaartifical intelligenceartificial intelligenceartificial lightarzerraascoasco 2019asco 2020asco 2021asco 2022asco 2023asco 2024ascorbic acidasctascular endothelial growth factor receptorashash 2014ash 2015ash 2016ash 2018ash 2019ash 2020ash 2021ash 2022ash 2023ash 2024ash2019ash2021asiaasianasparaginaseaspergillosisaspirateaspirationaspirinassayassociationasthmaastro 2024asymptomaticatclatezolizumabatf4atlatllatll. therapyatmatm geneatrial fibrillationaustrailiaaustralasiaaustraliaaustriaautlogousauto-sctauto3autograft absolute lymphocyte-to-monocyte count ratioautoimmuneautoimmune diseaseautoimmune hemolytic anemiaautologousautologous peripheral hematopoietic stem cell transplantationautologous stem cellautologous stem cell transplantautologuosautologusautophagyautosctavbdavdavelumabawarenessaxi celaxi-celaxicabtagene ciloleucelazacitidineazathioprineazd4573azerraazoospermiaaztb ccellb cellb cell receptorb lymphoblasticb-cellb-cell lymphomab-cell receptorb-cell receptor inhibitorb-cllb-llb2m mutationbacteriabacterialbaize'anbaize’anballoon endoscopybasal cell carcinomabatf3bavenciobcbcd-020bcl 2bcl 6bcl inhibitorbcl-2bcl-2 inhibitorbcl-6bcl2bcl2 expressionbcl2 inhibitorbcl2 inibitorbcl2 inihbitorbcl2 receptorbcl2 translocationbcl2-inhibitorbcl6bclubclwbclw mutationbcrbcr signalingbcr-inhibitingbeacbeacoppbeambecoppbehcet diseasebeleodaqbelgiumbelinostatbenchmarkbendamistinebendamustinebenzenebesponsabetbet protein bromodomain antagonistbeta 2 microglobulinbevacizumabbexarotenebexxarbfrbgb-3111bia-alclbiblosbimiralisibbinetbiologybiomarkerbiomarkersbiopsiesbiopsybiosimilarbiosimilarsbirabresibbirc3birc3 inactivationbirthbispecifcbispecificbispecific mosunetuzumabbitebkm120blbladderblasticblastoid variantbleedingbleomycinblinatumomabblincytoblindblitzimablk expressionblockadeblood brain barrierblood clotblood clotsblood donorblood pressureblood smearblood sugarblood testblood transfusionblood transmissionblood typebmibmt ctnbn2bnt162b2bnt16b2body compositionbody imagebody mass indexbody weightbompbonebone densitybone lossbone lymphomabone marrowbone marrow aspirationbone marrow biopsybone marrow fibroblastbone marrow involvementbone mineral densityborrelia burgdorferibortezombbortezomibbotezomibbotswanabowelbrbradycardiabrafbraf inhibitorbraf mutationbraf v600braf v600 mutationbraf v600ebrafv600e mutationbrainbrain fogbrain lesionbrazilbrca2 mutationbrcapbreastbreast cancerbreast implantbreast implant associatedbreast implant associated anaplastic large cell lympohmabreast implantsbreast implantâassociated anaplastic large-cell lymphomabreathing exercisebrentuximabbrentuximab vedotinbrexu celbrexu-celbrexucabtagene autoleucelbrexucabtagene autoleuelbreyanzibreyzanibridging therapybritainbritish colubiabritish columbiabriumvibrk inhibitorbromodomainbronchialbrukinsabrutnbrutonbruton tyrosine kinasebrutons tryosine kinasebrutons tryrosine kinasebrutons tyronsine kinasebrutons tyrosine kinasebrutonâs tyrosine kinasebrutonâs tyrosine kinase inhibitorbtg1btkbtk expressionbtk ihibitorbtk inhbitorbtk inhibitorbtk inhibitorsbtk inhibtitorbtk mutationbtkc481s proteinbtn162b2budgetbulgariabulky diseasebulky massbuparlisibburdenburkittburkitt'sburkittsburton tyrosine kinaseburtons tyrosine kinasebvc-c chemokine receptorc-c chemokine receptor 4c-myccachexiacadiovascularcalcitriolcalquencecamidanlumab tesirinecampathcamrelizumabcanadacanadiancancercancer carecancer experiencecancer imagingcancer incidencecancer related brain functioncancer related fatiguecancer researchcancer riskcancer survivorcandidiasiscap-vcrcarcar nkcar nk therapycar nk. immunotherapycar tcar t-cellcar-nkcar-tcar-t failurecar-t manufacturingcar19carbamatecarbohydrate antigen 125carboplatincarcinogenesiscarcinomacard11card11 mutationcardiaccardiac dysfunctioncardiavascular issuescardiomyopathycardiotoxiccardiotoxicitycardiovascularcardiovascular comorbidiescardiovascular diseasecardiovascular mortalitycardivascularcare modelscare plancaregivercaregiverscarfilzomibcaridovascularcarmustinecart19carteyvacastlemanâs diseasecat scancatastrophecather related thrombosiscathetercausecausescbclcc 292cccr4ccdn1ccnd2ccr4ccr4 monoclonal antibodycct036477cd 20 monoclonal antibodycd-19cd-20cd1cd10cd137 pathwaycd14cd15cd163cd19cd19 monclonal antibodycd19 monoclonal antibodycd1dcd20cd20 antibodycd20 expressioncd20 monclonal antibodycd20 monoclonalcd20 monoclonal antibodycd20 monoclonal antibodysurvivalcd20 negativecd20 positivecd22cd24cd27cd28cd3cd30cd34cd37cd38cd4cd44cd45rocd47cd47 monclonal antibodycd49dcd5cd56cd58cd68cd7cd70cd73cd78bcd79bcd8cd83cdk1cdk4 inhibitorcdk6cdk9 inhibitorcdkn1b mutationcdkn2acdkn2a deletioncelcellcell deathcell densitycell expressioncell free dnacell linescell mutationcell of origincell proliferationcell proteincell sheltercell signalcell surface receptorcell-free dnacell-in-cellcellular therapycental nervous systemcenter of origincentral nerous systemcentral nervouscentral nervous systemcentral nervous system involvementcentral nervouse systemcentral venous cathetercentral venous thrombosiscephalosporincerdulatinibcerebellumcerebrospinalcerebrospinal fluidcerebrumcervicalcervixcharacteristicschdcheckpointcheckpoint inhibitorcheckpoint blockadecheckpoint inhibitorcheckpoint inhibitorschemicalchemical exposurechemimmunotherapychemochemo brainchemo-refractorychemoetherapychemoimmunothearpychemoimmunotherapychemoimmunothrapychemoimmunothreapychemoimunnotherapychemokine receptor 4chemokineschemorefractorinesschemorefractorychemoresistancechemosensitivechemosensitive phasechemotheapychemothearpychemotherapychemotherapy regimenchemotherapy resistancecheomimmunotherapycheomotherapycheomtherapychicken poxchictr1800019622chidamidechildchild birthchildbearingchildbirthchildernchildrenchilechimericchimeric angtigen receptorchimeric anigen receptorchimeric anitgen receptorchimeric antigenchimeric antigen receptorchimeric antigen therapychinachinese medicinechlchlamydophila psittacichlorambucilchlormethinechn1choepcholecalciferolcholesterolchonic lymphocytic leukemiachopchop rchop-rchop21chornic lymphocytic leukemiachromosomechromosome banding analysischromosome microarray analysischromosonalchromosonechronicchronic health conditionschronic hepatitis c virus infectionchronic lmphocytic leukemiachronic lymphoc ytic leukmeiachronic lymphocyticchronic lymphocytic leuekmiachronic lymphocytic leukaemiachronic lymphocytic leukemaichronic lymphocytic leukemiachronic lymphocytic leukmeiachronic lymphocytic lymphocyticchronic lymphocytyic leukemiachronic lymphomcytic leukemiachronic lyphocytic leukemiachronic painchronis lymphocyticchronis lymphocytic leukemiacibmtrcircular ribonucleic acidscirculating tumorcirculating tumour dnacirmtuzumabcirrhosiscirscisplatincladribineclassicalclassical hodgkinclassificationclincal trialclincial trialclinica trialclinicalclinical trialclinical efficacyclinical guidelineclinical guidelinesclinical outcomeclinical studyclinical trialclinical trial eligibilityclinical trialsclivuscllcll chronic lymphocytic leukemiacll-hrscll11clonalclonal evolutionclonal hematopoiesisclonal heterogeneityclonalityclonesclozapinecnscnslco-codox-mcoexisting conditioncoexisting conditionscognativecognitioncognitivecognitive impairmentcognitive rehabilitationcohortcolitiscolombiacoloncolon cancercolonoscopycolonycolorectalcolorectal cancercoltuximab ravtansinecolumvicombinationcombination antiretroviral therapycombination therapycommunicationcomorbidiitescomorbiditescomorbiditiescomorbiditycomorbidity indexcomorbitiescomparisoncomplement factor hcomplete responsecomplexcomplex karyotypecomplicationcomplicationscomposite lymphomacomputed tomographycomputed tomograpyconcentrationconclusionsconcomitant cancerconcomitant medicationconcurrent cancerconditionconditional survivalconditioning chemotherapyconditioning therapyconditioning threapyconflict of interestcongestive heart failureconjunctivalconquer fearconsolidationconsolidation therapyconsultationcontinouscontrast enhancedcontrol armcontrolledcontrolling nutritional statusconvalescent plasmaconventional chemotherapycopanlisibcopiktracoptikracoronary arterycoronary artery diseasecoronary heart diseasecoronaviruscortactincorticosteroidcostcost effectivecost effectivenesscostscountcovid-19coxiella burnetiicrcranial aspergillosiscrebbpcrisprcrizotinibcroatiacrohns diseasecrscrucryptococcosisctct regimenct scanct scansct-p10ctclctdnactl019cumulative illness rating scalecurativecurative potentialcure ratecurrent treatmentcutaneouscutaneous b cellcutaneous diffuse large b cellcutaneous diffuse large b-cellcutaneous follicle centercutaneous marginal zonecutaneous t cellcutaneous t-cellcvmcvpcvp-rcxccxcr4cxcr4 mutationcycyclin d1cyclin dependent protein kinase 6cyclophosphamidecyp3a inhibitorcytarabinecytocytogeneticcytokinecytokine release syndromcytokine release syndromecytokinescytometriccytopeniacytopeniascytopgeneticscytosarcytostatic agentczech republicczechiad-dimerda-epochda-epoch-rda-r-epochdabrafenibdacarbazinedacetuzumab toxicdacogendaratumumabdarzalexdatadata sharingdatabasedbcldblcldcbclde novodeathdeauville criteriadebulkingdecision makingdecitabinedeficiencydeldel 17pdel17pdeletiondementiademographicdemographicsdendriticdendritic cellsdenileukin diftitoxdenmarkdenovo genomic markerdependent phosphorylationdepressiondermatitisdermatologydetectiondeveloped countriesdeveloping countriesdeveloping countrydevelopmentdexamethasonedffuse large b celldhapdhap-rdhldiabetesdiabeticdiagnosisdiagnosis to treatmentdiagnosticdiagnosticsdianosisdiarrheadieseldietdiffusediffuse largediffuse large b celldiffuse large b celldiffuse large b cell leg typediffuse large b cell lymphomadiffuse large b-belldiffuse large b-celdiffuse large b-celldiffuse large b-cell lymphomadiffuse-large b-celldiffusel large b celldigestiondigital pathologydimethylaminedinaciclibdioxindiscontinuationdiscontinuediscontinueddiscontinuingdiscordantdiseasedisease managementdisease progressiondisfunctiondistancedistressdlbcldlbcl diffuse large b celldlcldmdnadna methylationdna oligonucleotidedonordonor graftsdosagedosedose reductiondosingdouble expresserdouble expressiondouble expressordouble hitdouble hit b-celldouble primary cancerdoubletdoxorubicindoxorubicinm epocdpx-survivacdrinking waterdriver genedrugdrug accessdrug approvaldrug costdrug interactiondrug pricedrug pricingdrug reimbursementdrug resistancedrug reviewdual car-tdual targetingductal carcinomaduodenaldupilumabdurable responsedurvalumabdutchduvelisibdyslipidemiae colie-chope-lesionsearly deathearly detectionearly progressionearly stageearly treatmenteartly stageeastern europeebmtebmt 2023ebmt 2024ebstein barrebvechinocandinsechocardiographyeconomiceconomic burdeneconomic evaluationeconomic statuseconomyeczemaedemaederlyeditorialeducationeffective treatmenteffectivenessefficaciousefficacyefsegr2egyptehaeha 2019eha 2020eha 2021eha 2022eha 2023eha 2024elderlyelderly patientselectrocardiogramelectron beamelectronic helth recordeligibilityeliquiselotuzumabemaemission tomographyemotionemploymentemzblemzlencephalopathyend of lifeendemicendobronchial ultrasound guided transbronchial needle aspirationendoscopyendothelial activationendpointenglandengraftmentenhancer of zeste homolog 2enktlenrollmententecavirenteropathy associated t-cell lymphomaentinostatentklentospletinibenvironmentenzastaruinenzymeeol careepcoritamabepidazaepidemiologyepigeneticepigenetic age accelerationepigenetic dietepigenetic inhibitorepigenetic regulatorepigeneticsepigenomicepkinlyepochepoch repoch-repoetinepstein bar virusepstein barrepstein barr virusererbb4 expressionerythematosuseshapesmoesmo 2020esmo 2021esmo 2022esmo 2023essential medicineestoniaethinicityethiopiaethnicethnicityetopisodeetoposideeueuropeeuropean hematology associationeuropean medicines agencyeuropean society for medical oncologyeuropean unionevent freeevent free survivaleventseverolimusexerciseexome sequencingm mutationexon captureexpanded t-cellexpenseexportin 1exposureexpressionextra nodalextra nodal natural killerextra nodal nk t-cellextracorporeal photopheresisextranodalextranodal diagnosisextranodal diffuse large b cellextranodal disseminationextranodal marginal zoneextranodal natural killerextranodal natural killer t cellextranodal natural killer t-cellextranodal nk/t cellextranodal t-celleyeezbezh1ezh2ezh2 enzyme inhibitorezh2 inhibitorezh2 mutationezharmiaf-18-fluoro-2-deoxy-d-glucosef-box and wd40 repeat domain containing-7f-deoxyglucosef-fluorodeoxyglucosefacefact-gfactorsfamilialfamilial riskfamillalfamilyfamily historyfarmerfarmersfarnesyltransferase inhibitorfast growingfatiguefatigurefatty acidsfavezelimabfbxo11fbxw7fcafcrfcr-litefdafdcfdgfdg pet scanfdg-perfdg-petfdgâpositron emission tomographyfearfebrile neutropeniafecal transplantfemaleferritinfertilityfetalfetusfeverffsfibrinolysisfilgrastimfinancefinancesfinancialfindingfindingsfine needle aspirationfine needle biopsyfinlfinlandfirstfirst linefirst line treatmentfishfish oilfish testfist linefitfitnessfixed durationflflipifloridaflow cytometryfludarabeinfludarabinefludarabine-basedfludarbinefludaribinefluidfluid overload associated large cellfluorescence in situ hybridisationfluorescence in situ hybridizationfluorescent lightfluorine-18 fluorodeoxyglucosefluorodeoxyglucosefluorodeoxyglucoseâpositron emission tomographyfluoroglucoseflutterfmrfo-lbclfollicularfollicular dendritic cellfollicular helperfollicular helper t cellfollicular lymphomafollow upfollow-upfolotynfoodfood and drug administrationfox01foxo1foxp-1foxp1foxp3fractionatedfractionated cyclophosphamidefracturefracturesfragilefrailfrailtyfrancefratricidefrench guianafrist relapsefront linefront line therapyfront-line treatmentfrontlinefrontline therapyfrontline treatmentfrozen plasmafructosefuelfunctional assessment of cancer therapyfundfundingfungal infectionfungasfungoidesfungusfusionfzd1g csfg-clbg-csfg100ga101gait speedgalliumgasgastricgastric ulcergastrointestinalgazavagazavarogazyvagazyvarogbcgc-dlbclgcbgcet1gckgcllsggdp-rgelgelf positivegeltamogemcitabinegemoxgemox-rgemzargendergenegene editinggene expressiongene expression profilinggene mutationgene mutationsgene mutations. cytrabinegene profilegene sequencinggene therapygenesgeneticgenetic alterationgenetic alterationsgenetic analysisgenetic landscapegenetic make upgenetic markersgenetic mutationsgenetic profilegenetic testgeneticsgenitalgenolimzumabgenomegenome sequencinggenomicgenotypinggeptanolimabgeriatricgerm linegermangermanygerminal b cellgerminal b-cellgerminal centergerminal center b cellgerminal center b-cellgerminal centregermlinegifoxgliomaglobalglofitamabglucophageglucoseglucose transporter 3glut3glycoengineeredglycolysisglyphosategna13golcadomidegolidocitinibgp2013gpsgraftgraft versusgraft versus hostgraft versus host diseasegraft vs hostgraft-versus-host diseasegranulocytgranulocyte colony stimulating factorgranulocyte colony stimulating factorsgranulocytopeniagraph versus hostgraph versus host diseasegray zonegrazy zonegrey zonegrfsgs-9973guidelineguidelinesgutgut bacteriagut microbiomegut microbiotagvhdgynecologicalgzlh pylorih. pylorihaarthaematopoietichair cell leukemiahairy cellhairy cell leukaemiahairy cell leukemiahaplohaploidentical transplanthaplotypehbvhckhclhcthcvhcvihd-mtxhdachdac inhibitorhdac inhibitorshdtheadhead and neckhead cancerhealthhealth carehealth economicshealth equityhealth literacyhealth technology assessmenthealthcarehealthcare costhealthlyheartheart attackheart diseaseheart failureheart problemheart problemsheart rateheavily treatedhedgehog signalinghelicobacter pylorihelioshematologic malignancieshematopoietichematopoietic cellhematopoietic cell transplanthematopoietic cell transplantationhematopoietic stem cell transplanthematopoietic stem cell transplantationhematopoietic stem-cell transplantationhemoglobinhemophagocytic lymphohistiocytosishemophiliahemorrhagehemostasishemotopoietichepatichepatic failurehepatitishepatitis ahepatitis bhepatitis chepatitushepatosplenic t cellhepatosplenic t-cellherherbal medicineherbicideherbicidesherpes zosterhhv8hibrukahigh blood pressuehigh dosehigh dose chemotherapyhigh dose cthigh gradehigh riskhigh-dose methylprednisolonehispanichistiocytehistiocyteshistolic transformationhistologic transformationhistone deacetylasehistone deacetylase inhibitorhistone deacetylaseshistoricalhistoryhivhiv relatedhlhla typehlx01hodginhodgkinhodgkin lymphomahodgkin'shodgkin's lymphomahodgkinshogkinholaholistichollandhong konghospitalhospitalisationhosthost diseasehr001hrombocytopeniahscthsp90hsp90 inhibitorhstlhtahtlvhtlv 1htlv-1hu5f9-g4hucart-19hugaryhuman development indexhuman herpesvirus type 8human immunodeficiency syndromehuman immunodeficiency virushuman leukocyte antigenhuman t cell lymphotropic virus type 1human t-cell leukemia virus type 1human t-cell leukemia virus-1humoralhungaryhybrid immunityhybrytehyper cvadhypercalcemiahypercinhypercvadhyperfractionated radiationhyperglycemiahypericin photodynamichyperkalemiahyperphosphatemiahyperplasiahypertensionhypoalbuminemiahypofractionated radiationhypogammaglobulinemiahypokalaemiahypomagnesemiahyponatremiahypophosphatemiahypoxiahysterectomyi3ciatrogenic immunodeficiency-associated lymphoproliferative disordersib1308ibdibranceibritumomabibritumomab tiuxetanibrutinbibrutinibibrutinib failureibrutinib resistanceibrutinib resistantibrutnibicanicansicml 2019icml 2021icml 2023icrt14ictidalalisibidarubicinidasanutlinidela + ridela+ridelalisibido1idolentifosfamideifrtig-htsigg4ighighvighv geneighv genesighv mutationighv3-21ighv4-39igll5iglv3-21igmigrtigvhigvh mutationihciiil-13il-15il-2il-21il10rbil2rgil32il4r mutationileocecal areaillnessimagingimaging mass cytometryimbruvicaimbruvica resistanceimfinziimidazoquinolinesimmune cellimmune checkpointimmune checkpoint inhibitorimmune checkpoint inhibitorsimmune dysregulationimmune effector cell associated neurotoxicityimmune effector cell associated neurotoxicity syndromeimmune effector cell neurotoxicity syndromeimmune functionimmune infiltrationimmune intermediateimmune modulationimmune poorimmune reconstitutionimmune responsesimmune restorationimmune richimmune signaturesimmune systemimmune thrombocytopeniaimmunisationimmunityimmunochemistryimmunochemotherapyimmunodeficiencyimmunodficiencyimmunogloblulin heavy chain variableimmunoglobulinimmunoglobulin gene rearrangementimmunoglobulin genesimmunoglobulin heavy chainimmunoglobulin heavy chain translocationimmunoglobulin heavy chain variableimmunoglobulin heavy chain variable regionimmunoglobulin replacement therapyimmunohistochemistryimmunomodulatoryimmunomodulatory agentsimmunopeptidomeimmunophenotypingimmunoradiotherapyimmunosuppressantimmunosuppressionimmunosuppressive therapyimmunotherapyimmuontherapyimplantimplantable venous access portsimproved survivalinbrutinibincidenceincidence rateincomeincreased riskindexindiaindigenousindividual therapyindole-3-carbinolindolentindolent non-hodgkinindolent patientsindonesiainductioninduction therapyindustryinfantinfared spectroscopyinfectioninfection rateinfectionsinflammationinflammatory bowel diseaseinflammatory skin diseaseinfliximabinformationinfradiaphragmaticinfusioninfusion reactioninfusion timeinfusional toxicityinhibitedinhibitioninhibitorinhibitorsinhlinitial treatmentinjectioninotuzumab ozogamicininpatientinsectinsecticideinsecticide treated bed netinsulin resistanceinsuranceintensiveintensive careintensive chemotherapyintensive therapyinterferoninterferon alphainterferonsinteriminterleukininterleukin 2interleukin 21interleukin-13intermediateinternational conference of malignant lymphomainternational conference on malignant lymphomainterstitial lung diseaseinterventionintestinalintestineintoleranceintolerantintraocularintraoperative cytologyintrathecalintrathoracic infectionintravascular large b bellintravascular large b cellintravenous immunoglobulinintronic polyadenylationinverse probability weightinginvestigator assessed pfsinvolved field radiationinvolved site radiationiodine-131-rituximabiomiopofosineiph4102ipiipi-145ipi145ipilimumabirafiraniraqirelandirf4irf4 rearrangementirf8 transcriptionirradiationirritable bowel diseaseisdotaxisraelistodaxitacitinibitalianitalyitchingivacivlbcliwcll 2023ixazomibjakjak inhibitorjak kinasejak statjak-statjak/statjak/stat inhibitorjak1 inhibitorjak2 inhibitorjak3 pathwayjakafijanus kinasejapanjapanesejaw bonejaypircajcar014jcar017jordanjulietjunbk167kaplan meierkaplan-meier curveskaposi sarcomakappa specifickarotypekaryotypekayotypekdkenyaketogenicketone bodieskeytrudaki-67ki-67 expressionki-76ki67kidneykidney diseasekidney injurykidskif23kinasekir3dl2kiteklebsiella pneumoniaeklf2m notch2kmt2ckmt2dknowledgekoreakoreankraskuwaitkw-0761kymriahkyprolisl-asparaginasel-asparaginsel265plactate dehydrogenaselactic dehydrogenaselacutamablag-3 inhibitorlamp1lance armstrong foundationlarge b-cell lymphomalarge cell transformationlaryngeal edemalate effectslate onset neutropenialatin americalatinolatvialdhldh serumlebanonleg typelenlenaldiomidelenaldomidelenalidomidlenalidomidelenalidomide maintenancelenealidomideleptomeningeal diseaseless than 65leukapheresisleukemialeukemic follicularleukemic phaseleustatleustatinlevelslglicenselifelife expectancylife yearlifestylelightlight chainlimited carelimited stagelimited stage relapselinklinperlisiblipidlipidslipoproteinliposomalliposomal doxorubicinliquid biopsylisaftoclaxliso celliso-celliso-celllisocabtagene maraleucellisocabtangene maraleucellitakliteklithuanialiverliver failurelmo2lnalidomidelocal failure ratelocationlocoregionally recurrentloncastuximab tesirinelong termlong term effectslong term survivalloplorbrenalorlatiniblow doselow gradelow gradeslow incomelow microbial dietlow risklow toxiclow toxicitylow triiodothyroninelow tumor burdenlow-doselow-grade b cell lymphomalphllpllr-dlbcllrp1blumber canallumber puncturelumoxitilunglung cancerlung diseaselung involvementlunsumiolupuslv20.19lymphadenopathylymphoblasticlymphoblastic lymphomalymphocytelymphocyte monocyte ratiolymphocyteslymphocyticlymphocytosislymphocytosis transmissionlymphodepletionlymphomalymphoma of bonelymphoma researchlymphoma risklymphoma-initiating cellslymphomatoid papulosislymphopenialymphoplasmacyticlymphoplasmacytic lymphomalymphoplasmaticlyphocyticlysalysism0r00208m7flipimabcampathmabtheramabthera maintenancemachine learningmacrophagemacrophagesmagnesiummagnetic resonancemagnetic resonance imagingmaintenace therapymaintenancemaintenance therapymalariamalat1malawimalemale breast cancermalignanciesmalignancymalignantmalignant cellsmalignant lymphomamalnutritionmaltmalt1 genemammogrammanageable toxicitymanagementmandiblemanitobamantle cellmantle cell lymphomamanufacturemanufacturingmanufacturing failuremao-amapmap2k1mapk/erkmarginal residual diseasemarginal zonemarital statusmarkermarkersmarket authorisationmarriagemarrowmastectomymaternalmaternal agemaveropepimutmax residual diseasemaxillamaximum standardized uptake valuemayomblmcdmclmcl co-culturemcl1meatmechanismmechanismsmechanistic target of rapamycinmechlorethaminemed12mediastinalmediastinal radiationmedicaidmedicaremedicationsmeditationmef2b mutationsmelanomamelphalanememorymenmenstrationmental healthmentle cellmesamesenchymal stromal cellsmetabolicmetabolic syndromemetabolic tumor volumemetabolic tumour volumemetabolismmetforminmethotrexatemethylationmethylenetetrahydrofolate reductasemethylomemetronidazolemexicomfmgzlmicro-rnamicrobalmicrobialmicrobiomemicrobiotamicroenvironmentmicroglobulinmicrornamicrosatellite instabilitymiddle eastmil62mild toxicitymindfulnessminimal residual diseaseminimal residucal diseaseminimal residue diseaseminimal risidual disease negativityminingmipimipi-bmir 124amir-150mir-18bmirnamismatch donormitochondriamitochondrialmitogen activated protein kinasemitoxantronemitoxantrone hydrochloride liposomemixantronemixed cellularitymlh1mln8237modelmodernamogamogamulizumabmolecularmolecular diseasemolecular heterogeneitymolecular high grademolecular pathwaysmolecular sub-typesmoleculesmolnupiravirmompmonclonal antibodymonjuvimonoamine oxidasemonoclonalmonoclonal antibodiesmonoclonal antibodymonoclonal b cell lymphocytosismonoclonal b-cell lymphocytosismonocytemonocytic myeloid derived suppressive cellsmonotherapymonsunetuzumabmoppmor208morbiditiesmorbiditymortalitymortality ratemosquitomosunetuzumabmotherhoodmouthmoxetumomab pasudotoxmrmrdmrd guidedmrd minimal residual diseasemrd-negative crmrimrnamrna-1273msdmthfrmtormtor inhibitormtor pathwaymtvmuccosa associated lymphoid tissuemucosa associated lymphoid tissuemucosa-associated lymphoid tissuemucosal lymphoid proliferationmulti agentmulti centremulti-center studymulticentermultiple cancersmultiple lymphomatous polyposismultiple myelomamultiple primary malignanciesmum1muscle lossmuscle massmutant-allele tumor heterogeneitymutatedmutated genesmutationmutationsmyalgiamycmyc expressionmyc genemyc rearrangementmyc rearrangmentmyc translocationmyc-ig translocationmycocis fungoidesmycosismycosis fungoidemycosis fungoidesmydmyd88myd88 l265p mutationmyd88 mutationmydd88 mutationmyeloablativemyelodysplastic syndromemyelodysplastic syndromesmyelofibrosismyeloidmyeloid neoplasiamyelosuppressionmyocardial infarctionmyocarditismyostatinmyvaxmzln/k t-celln1nanoparticlenaratuximab emtansinenasalnasal cavitynasal typenasal-typenasopharynxnational comprehensive cancer networknatural killernatural killer cellnatural killer t-cellnatural killer t-cell lymphomanatural language processingnatural t-cellnauseanavitoclaxnccnnccn 2022nct01732913nct01732929neckneck cancerneedle core biopsynemtabrutinibneonatalneoplasmnervous systemnetherlnetherlandnetherlandsnetupitantneulastaneupogenneurologicalneuropathyneurotoxcityneurotoxicityneutophilneutralizing antibodiesneutropenianeutropenic dietneutrophilneutrophilsnew diagnosisnew drugsnew zealandnewly diagnosednewsnext gereration sequencingnf-kbnfatc1ngsnhlnicotinenightnilaroninlaronipentnitrogennitrogen dioxidenitrogen mustardnivolumabnknk carnk cellnk t cellnk/t cellnk/t-cellnkctlnktclnktlnlnlphlnodalnodal marginal zonenodular lymphocyte predominantnodular lymphocyte predominant hodgkinnodular lymphocyte predominant hodgkin lymphomanodular lymphocyte predominant hodgkin'snodular lymphocyte-predominant hodgkin lymphomanodular lymphocytic predominantnodular sclerosisnodular sclerosis syncytialnomogramnon cytotoxic therapynon favourablenon gcbnon germinal centernon hodgkinnon hodgkin's lymphomanon-gcbnon-germinal centernon-hodgkinnon-hodgkin lymphomanon-steroidal anti-inflammatory drugnon-toxicnonablativenoncovalentnonmyeloablative hla-haploidentical bloodnonpharmacologicnordicnorwaynosnot otherwise specifiednotchnotch1notch2novelnovel agentsnovel therapiesnovel therapynovel treatmentnulticenternursenutritionobeseobesityobintuzumabobinutuzimabobinutuzumabobservationobservation. studyobservationaloccupationoccupational exposureoct-1ocularocular adnexaocular adnexalocular adnexal mantle-cellodronextamabofa mini chopofatumumabofotlertuzumabointmentoldolderoleaceinoleocanthaloligozoospermiaolive oilomicronomized study efficacyoncasparoncologistoncologyoophorectomyopdivioopdivoopen labelopen-labelophthalmicopinionopioidopticaloptionsororaloral therapyorbitalordsponoorelabrutiniborgan disfunctionorgan involvementorgan transplantorganicorganochlorineorganophosphorusoriginorphan designationorphan drugsorrososteonecrosisosteoporosisosteosarcopeniaosteosclerosisoutcomeoutcomesoutdoor lightoutlookoutomce eventsoutpatientoutsomeovarianovarian failureovaryoveral survivaloverall response rateoverall survialoverall survivaloverall survival rateoverall survivalloverall suvivaloverviewoverweightoxoxaliplatinoxidationoxidative stressp wave parameterp-gdpp13kp13k inhibitorsp53p53 mutationpacificpainpain managementpakistanpalbociclibpalliativepalliative therapypalonosetronpancreaspancreaticpandemicpanniculitispanniculitis t-cellpanobinostatparacetamolparanasal sinusesparaneoplastic syndromeparenthoodparp1parsaclisibpartial remissionpast treatmentpateientpathogenesispathological diagnosispathwaypathwayspatientpatient experiencepatient managementpatient preferencepatient registrypatient reported outcomepatient selectionpatient submissionpatientspb-dlbclpblpbscpcaetlpcbclpcdlbclpcfclpcgd-tclpcmzlpcnspcnslpcppcr testpd-1pd-1 blockadepd-1 follicular t helperpd-1 inhibitorpd-1 inhibotorpd-1 inhibtorpd-l1pd-l1 inhibitorpd-l2pd1pd1 inhibitorpdl1pdmapediatricpediatric follicularpediatric staging systempeg-asppegasparaginasepegaspargasepegfilgrastimpembolizumabpembrolizumabpembrolizumab and radiation therapypembrolizuumabpentostatinpeptideperchloroethylenepercutaneouspericardial effusionpericardiumperinatalperiorbitalperipheralperipheral nervous systemperipheral neuropathyperipheral neuropathyjperipheral t cellperipheral t cell diffuse large b cellperipheral t-cellperipherally inserted central cathetersperipherial t cellperson centred carepersonalised therapyperupesticidepetpet ctpet scanpet-ctpet/ctpf-05280586pfizerpfspfs ratepgdlbclpharmaceuticals and medical device agencypharmacistpharmacodynamicpharmacokineticpharmaconkineticphase 1phase 2phase 3phase iphase iiphase iiiphenotypephenotypesphenoxyherbicidephilippinesphosphatase and tensin homolog proteinphosphatephosphatidylinositol 3 kinasephosphatidylinositol 3 kinase deltaphosphatidylinositol 3-kinasephosphatidylinositol 3-kinase inhibitorphosphoinositidephosphoinositide 3 kinasephosphoinositide 3 kinase inhibitorsphosphoinositide 3-kinasephosphoinositide 3-kinasesphospholipase c gamma 2photopheresisphototherapyphthalatephysical activitypi3 kpi3-kinase inhibitorpi3kpi3k inhibitorpi3k inhibtorpi3k mutationpimpim kinasespim1pinatuzumab vedotinpirarubicinpirtobrutinibpixantronepixurvipixuvripkf118-310placebiplaceboplasma dnaplasma micronaplasmablasticplasmablastic lymphomaplasmodium falciparumplasticityplasticsplateletplatelet lymphocyte ratioplatelet to lymphocyte ratioplateletsplcg2pleomorphicpleomorphic variantplerixaforpleural effusionpmbclpmblpmlblpneumococcal vaccinepneumocystis carinii pneumoniapneumocystis jirovecipneumocystis jiroveciipneumocystis pneumoniapneumoniapneumonitispoamlpod24polpolandpolatuzumabpolatuzumab vedotinpolivypollutionpolymerase chain reactionpolymorphismpolypharmacypolypoidpoorpoor prognosisporgnosticportugalpositivepositive cellpositive emission tomographypositronpositron emissionpositron emission tomgraphypositron emission tomographypositron emission tomograpypositron emission tomogrpahypositron emisssion tomographypositron emmission tomographypositron tomographypositron tomography emissionpost germinal centerpost hoc analysispost transplantpost transplant lymphoproliferative disorderpost traumatic stress syndromepost treatmentpost-transplant lymphoproliferative disorderpost-treatmentposterior uveitispot1poteligeopplpracticepractice guidelinespralatrexatepre phasepre treatedpre-mrna splicingpreclinicalprecursorpredictpredictingpredictionpredictivepredictorprednisonepreganancypregnancypregnancy associatedprembrolizumabpresentationpreterm birthpretreatedprevalenceprevelancepreventionpreviouse treatedpreviouslypreviously treatedpreviously untreatedpreviously untreated patientspreviousy treatedprgonosticpriceprimaprimaryprimary adrenalprimary boneprimary breastprimary cardiacprimary central nervous systemprimary central nervous system lymphomaprimary cnsprimary cutaneousprimary cutaneous aggressive epidermotropic cytotoxic cd8primary cutaneous anaplastic large cellprimary cutaneous b-cell lymphomaprimary cutaneous diffuse large b cellprimary cutaneous follicle centerprimary cutaneous gamma deltaprimary cutaneous marginal zoneprimary effusionprimary effusion lymphomaprimary gastricprimary gastrointestinalprimary gastrointestinal follicularprimary genitalprimary hepaticprimary intestinalprimary intraventricularprimary mediastinalprimary mediastinal b cellprimary mediastinal b-cellprimary mediastinal large b cellprimary mediastinal large b-cellprimary ocularprimary orbitalprimary organprimary ovarianprimary pancreaticprimary pituitaryprimary pulmonaryprimary pulmonary intravascularprimary renalprimary seminal vesicleprimary small intestinalprimary spinal epiduralprimary splenicprimary testicularprimary thyroidprimary tongueprimary uterineprimary vitreoretinalprior cancerprior treatmentprizlon-celprizloncabtagene autoleucelprkcdprobioticsprocarbazineprodigyprofileprogessionprognosisprognosis indexprognosticprognostic factorprognostic factorsprognostic indexprognostic marketprognostic modelprognostic scoreprognostic testprognosticatorprogosticallyprogramprogram deathprogramed death cellprogrammed cell deathprogrammed deathprogrammed death cellprogrammed death ligandprogrammed death ligand 1programmed death-ligand 1programsprogress free survivalprogressionprogression fee survivalprogression freeprogression free surivivalprogression free survivalprogression free survivialprogression of diseaseprogression-freeprogression-free-survivalprogressiveprolonged response rateprompronosispronosticprophylacticprophylaxisproposalprostateproteasome inhibitorproteinprotein energy malnutritionprotein expressionproteinsproteobacteriaprotocadherinprotonproton beam therapyproton pump inhibitorproton therapyproviralpruritisprurituspscnslpsenhlpseudoprogressionpsnslpsoriasispsychologicalpsychosocialpsycologicalptptclptcl-nosptlptnflptprd lesionsptspts selectionpubertypublicationpublicly fundedpulmonarypulmonary embolismpurine analogpurine nucleoside analogpurpuric rashpuvapvrlpyschosocialq feverqalyqolquadruple hitquality adjusted life yearquality adjusted life yearsquality of liferr chopr cnopr compr cytarabiner dhapr epochr hdacr hdsr-chemor-chlorambucilr-choep-14r-chopr-compr-cvpr-dhapr-epochr-gemoxr-hdcr-high doser-monor2rac1raceracialracial disparityradation therapyradiationradiation exposureradiation free therapyradiation therapyradiation treatmentradio labelled antibodyradio sensitiveradio therapyradio-sensitiveradioimmunotherapyradiologicalradiotheapyradiothearpyradiotherapyrandomisedranger prorapcabtagene autoleucelrapid onsetrarerare diseaserchemorchoprchprcor1rdwreactionreactivationreactive proteinreal wordreal worldrealpsereasearchrebiopsyreceptorrecombinant human gcsfrecommendationrecordsrecruitementrecurrencerecurrent primary central nervous system lymphomared blood cell distributionred blood cell distribution widthred cellred cell distributionred cell distribution widthreddituxredituxreduced dosesreduced intensityreduced intensity conditioningreductase inhibitorreed-sternbergrefactoryrefractorrefractoryrefractory auto4refractryrefratoryregimanregimeregimenregistriesregistryregulationregulatoryregulatory drug approvalregulatory t cellrehabilitationreimbursementreivewrelapasedrelapserelapse free survivalrelapse refractoryrelapsedrelapsed cllrelapsed follicular lymphomarelapsed mantle cell lymphomarelasperelaxationrelma-celrelmacabtagene autoleucelrelpaserelpasedremdesivirremetinostatremissionremission rateremote monitoringrenalrenal functionrenal toxicityreoccurancereplapsedreponsereportreportedreproductionrescueresearchresidualresidual diseaseresiquimodresistanceresitanceresonatetmrespiratoryrespiratory infectionrespiritoryresponseresponse rateresponse ratesresultresultsretinaretinoicretinoidretreatmentretrospectivereturn to workreviewrevilimidrevlimidrevlimiderexolitinibrheumatoid arthritisrhinitisrhoa mutationribosomeribvdricrichterrichter syndromerichter transformationrichter'srichter's syndromerichtersriskrisk autoimmunerisk benefitrisk factorsrisk reductionrisk stratificationritemviarituxambrituxanrituxan. cd20 monoclonal antibodyrituxiambrituximabrituximab biosimilar hlx01rituximab maintenancerituximab monotherapyrituximab resistancerituxmiabrituxumabrituzenarixathonriximyornaromaniaromidepsinror1ror1 inhibitorros generationround uprounduproutinerps15 mutationrras2rtrtxm83ruminococcusrunx3ruralrussiarussian federationruxienceruxolitinibruxolitnibrvrss1pr2safetysafety side effectsafeysaffetysafteysakksalivary glandsalvagesalvage therapiessalvage therapysalvagedsar3419sarcoidosissarcopeniasars-cov2sasr-cov2satisfactionsaudi arabiascanscansscd163schizophreniaschoolscnsscnslscotlandscreeningsctseasonalitysecondsecond canceersecond cancersecond dosesecond infusionsecond linesecond lymphomasecond malignancysecond primary malignanciessecond primary malignancysecondary antibody deficiencysecondary cancersecondary cancerssecondary central nervous systemsecondary issuessecondary maliganciessecondary malignanciesseizureselinexorsemensenagalsenegalsepticsequencingseromaserumserum albuminserum iggserum immunoglobulinserum proteinsevere acute graftsexsexual dysfunctionsexual healthsezarysezary syndromesf3b1sgx301shapeshelterinshinglesshortagesicksickle cellside efectside effecside effectside effectsside efffectsigmsignalsignalingsignaling pathwaysignallingsignalling pathwayssignssilencingsilâ2rsimian virussingaporesingle agentsingle armsingle centresingle injectionsingle nucleotide polymorphismsinonasalsintilimabsinussirolimussirt1 rs3758391sirt3sjogren diseasesjogren syndromeskeletal muscleskinskin biopsyskin cancerskin pigmentskullsleepsllslovakiasloventsmall lymphocyticsmall lymphocytic leukemiasmall lymphocytic lymphomasmall volume biopsysmart technologysmilesmokingsmolderingsmudge cellsmzlsnt-dlbclsobuzoxanesocialsocial determinantsocial statussocioeconomicsocs1sod2soft tissuesoho 2020soho 2021soho 2022soho 2023soho 2024solid tumorsolid tumoursolventsomatic driver mutationssouth africasouth koreasox11spainspectrumspenspermspike proteinspinal canalspinal fluidspindlespindle cellspinespleenspleen tyrosine kinasesplenectomysplenicsplenomegalyspmsspmzlspontaneousspontaneous regressionspontaneous remissionspousesptclsquamous cell carcinomassstagestage 1stage 2stage 3stage 4stage istage iastage iiistage ivstagingstaging systemstandard treatmentstanford vstat3stat5stat6statinstatistical modelstatisticsstemstem cellstem cell transplantstem cell transplantationstem cells transplantationstem-cell transplantstereotactic radiosurgerysteriodsteriodssteroidsting agonistsstomachstrategiesstrategystratificationstrengthstressstrokestromalstudaystudiesstudystudy endpointstudyâ in vitrosub-typesubclonalsubclonal mutationssubcutaneoussubcutaneous panniculitissubcutaneous panniculitis-like t-cell lymphomasubcutaneous rituximabsubretinal pigment epithelial infiltrationsubtypesubtypessubuzoxanesugarsugemalimabsuggestionsuicidesunsun exposuresunitinibsupportsupportive caresupradiaphragmatic radiotherapy. therapysurgerysurivalsurivivalsurrogate end pointsurrogate endpointsurveillancesurveillance imagingsurveysurvialsurvivalsurvival ratesurvivaljsurvivesurvivin expressionsurvivorsurvivorshipsurvivorship care plansurvivorship/lifestylesuvsuvivalswedensweetswitzerlswitzerlandsyksyk inhibitorsyk jak inhibitorsymptomsymptom controlsymptomssynchronous lymphomasynchronous primary cancerssynchronus lymphomasyncytial variantsynthetic hypericinsyzary syndromeszeary syndromet cellt cell dysfunctiont cell exhaustiont cell hisiocyte rich large b cellt cell memoryt cell nk t cellt cell receptort-cellt-cell fitnesst-cell immunityt-cell immunotherapyt-cell lymphomat-cell lymphomast-cell receptort-llt/nk-cellt3 syndrometacalcitoltachyarrhythmiatachypneatafasitamabtafastimambtai chitaiwantak-007tamstandem transplanttanktanzaniatargettargetedtargeted agentstargeted b-cell receptortargeted therapiestargeted therapytargetingtargetstargettedtargretintattootazematostattazemetostattazveriktblr1tcltcr sequencingteatmenttecartustecentriqtelehealthtelmisartantelo-hltemozolomidetemsirolimoustemsirolimustenalisibtepkinlytesttesticletesticulartestistestosteronetet2tetrachloroethylenetetrahyfropyranyladriamycintevimbratfhltg-1101tg-1202tgr-1201tgr-1202thailandthalidomidetherapeutictherapeutic targettherapiestherapies immunochemotherapytherapytherpythiopurinesthiotepathiropurinesthoracicthp-copthp-cop. pirarubicinthrlbclthrombocytopeniathrombosisthroughput sequencingthymusthyroidthyroid cancertime limitedtime of daytime to first treatmenttime to next treatmenttime to progressiontime to treatmenttipifarnibtirabrutinibtirednesstisa-celtisa-cel dlbcltisa-cel kymriahtisagenlecleuceltislelizumabtissue dnatiuxetantlstls. safetytnfrsf14tobaccotocilizumabtoll-like receptortomographytoolstopicaltopical calcineurin inhibitortopical corticosteroidstopical retinoidstopical therapytoriseltositumomabtotal body irradiationtotal lesion glycolysistotal skin electron beamtoxtoxcitytoxictoxicitiestoxicitytoxicity adverse eventtoxicity profiletoxictytp53tp53 mutationtp53 mutationstp53c-myctq-b3525trametinibtranscriptiontranscriptional profilingtransducin β-like receptor 1transformtransformationtransformedtransformed folliculartransfusiontranslocationtranslocationstranslplanttransplanttransplant ineligibletransplantation and cellular therapy 2023traveltreamenttreamtmenttreatmenttreatment accesstreatment adherencetreatment failuretreatment free survivaltreatment intensitytreatment naã¯vetreatment optionstreatment planningtreatment regimentreatment resistancetreatment responsetreatmentstregtregstrem2trendtrendstreosulfantretmenttrialtrialstrichloroethylenetriple hittriple lymphomatriplettrisomytrisomy 12trispecifictrmtrofosfamidetruximatsebtuberculosistucidinostattumortumor burdentumor lysis syndrometumor microenvironmenttumor necrosis factortumor stem cellstumor volumetumourtumour bulktumour burdentumour locationtumour lysis syndrometumour microenvironmenttumour volumeturkeytuxellatwist1tyk2typetype iityrosinetyrosine kinasetyvytublituximabublituxumabucart7uch-l1uch1uclear magnetic resonanceugandaukukoniqukraineulcerulcerativeulcerative colitisultrasoundultravioletultraviolet lightultraviolet therapyumbilical cordumbillical cordumbralisibunfavorableunfitunited kingdomunited statesuniversalunstageduntied statesuntreateduntreated follicularuorodeoxyglucose positron emission tomographyurbanurinaryurinary tracturvivalususauterine cervixuterusutomilumabuvav600evaccinationvaccinevaccine hesitancyvalcadevalemetostatvalemetostat tosylatevalvular dysfunctionvancouvervar-celvariably low surface immunoglobulinvariantvaricellavarnimcabtagene autoleucelvascular endothelial growth factorvecabrutinibvedotinvegfr1velcadevelexbruvemurafenibvenclextavenclextovenclyxtovencylxovencylxtovencylyxtovenetoclaxvenousvenous thromboembolismventricular arrhythmiaventricular systolic functionvenus thrombosisvenxclextavenxclyxtovenxcylxtoversusvinblastinevincristinevinorelbineviralviral sheddingvirtual biopsyvirtual carevirusvision lossvitaminvitamin avitamin cvitamin dvitreoretinalvomitingvorinostatvoriostatvorisnostatvoxtalisibvr chopvr-capvrtual carewaldenstromwaldenstrom macroglobulinemiawaldenstrom's macroglobulinemiawaldenstromâs macroglobulinaemiawaldeyer ringwatch and waitweakwee1weightweight losswell tolerated therapywestern europewhite blood cellwhite blood countwhite matter lesionwhole exomewhole exome sequencingwhole foodswhsc1whsc1 mutationwidthwild typewmwmctgwnt3womanwomenworkworld health organizationworryx rayx-rayxl765xp01 inhibitorxpo1xpo1 inhibitorxpovioyervoyyescartayescarta relapseyescatayogayoundyoungyoung adultyoungeryouthyttrium-90zambiazamto-celzamtocabtagene autoleucelzandelisibzanubrutinibzap 70zap70zeb1zelborafzevalinzevelinzidovudinezilovertamabzilovertamab vedotinzolinzazydeligzynlontaâ amd3100â anti-cd20â cxcr4â dlbclâ drugâ plerixaforâ rituximabApproval StatusApproval declinedApproval withdrawnApproved for saleNo approval statusPending approvalPhase III Clinical TrialPharmaceutical Company4SCAbbvieAcerta PharmaADC TherapeuticsAkeso BioAllosAmgenAptevo TherapeuticsAstraZenecaBayerBeiGeneBionpharmaBristol Myers SquibbCelgeneCelltrionCephalonCitius PharmaceuticalsCTI/ServierDaiichi SankyoDenovo BiopharmaDizal PharmaceuticalDr. Reddy's LaboratoriesEisaiEli LillyEpizymeGenetechGenmabGenta DevelopmentGenzymeGilead SciencesGloria BiosciencesHospiraHUYA BioscienceHybrigenicsImmuneel TherapeuticsImmunomedicsIncyteInnoCareInnovent BiologicsJanssenJiangsu Hengrui MedicineJuno TherapeuticsJW TherapeuticsKaryopharm TherapeuticsKITEKyowa KirinLigand PharmaceuticalsmAbxienceMedImmuneMEI PharmaMerckMorphoSysNovartisOno PharmaceuticalOnxeoOnyxPfizerPharmacyclicsRegeneron PharmaceuticalsRocheSandozSanofi PasteurSeattle GeneticsShandong New Time PharmaceuticalSinocelltechSoligenixSpectrumSyndaxTakedaTevaTG TherapeuticsToleroUCB PharmaValeantVerastemZiopharmSubtypesAnaplastic Large Cell 1st LineAnaplastic Large Cell Relapse/RefractoryAdult T-cell 1st LineAdult T-cell Relapse/RefractoryBurkitt's 1st LineBurkitt's Relapse/RefractoryCLL 1st LineCLL Relapse/ RefractoryCutaneous T-cell 1st LineCutaneous T-cell Relapse/RefractoryDLBCL 1st lineDLBCL Relapse/RefractoryNK/T-cell 1st LineNK/T-cell Relapse/RefractoryFollicular 1st LineFollicular Relapse/RefractoryHairy-cell 1st LineHairy-cell Relapse/RefractoryHodgkin 1st LineHodgkin Relapse/RefractoryMantle Cell 1st LineMantle Cell Relapse/RefractoryMarginal Zone 1st LineMarginal Zone Relapse/RefractoryPrimary Cutaneous ALCL 1st LinePrimary Cutaneous ALCL Relapse/RefractoryPeripheral T-Cell 1st LinePeripheral T-Cell Relapse/RefractoryWaldenstrom 1st LineWaldenstrom Relapse/RefractorySubtypesAnaplastic Large Cell 1st LineAnaplastic Large Cell Relapse/RefractoryAdult T-cell 1st LineAdult T-cell Relapse/RefractoryBurkitt's 1st LineBurkitt's Relapse/RefractoryCLL 1st LineCLL Relapse/ RefractoryCutaneous T-cell 1st LineCutaneous T-cell Relapse/RefractoryDLBCL 1st lineDLBCL Relapse/RefractoryNK/T-cell 1st LineNK/T-cell Relapse/RefractoryFollicular 1st LineFollicular Relapse/RefractoryHairy-cell 1st LineHairy-cell Relapse/RefractoryHodgkin 1st LineHodgkin Relapse/RefractoryMantle Cell 1st LineMantle Cell Relapse/RefractoryMarginal Zone 1st LineMarginal Zone Relapse/RefractoryPrimary Cutaneous ALCL 1st LinePrimary Cutaneous ALCL Relapse/RefractoryPeripheral T-Cell 1st LinePeripheral T-Cell Relapse/RefractoryWaldenstrom 1st LineWaldenstrom Relapse/RefractoryCountryAlgeriaArgentinaArmeniaAustraliaAustriaBarbadosBelarusBelgiumBosniaBrazilBulgariaCanadaChileChinaColombiaCosta RicaCroatiaCzechiaDenmarkDominican RepublicEcuadorEgyptEl SalvadorEstoniaFinlandFranceGeorgiaGermanyGreeceGuatemalaHong KongHungaryIndiaIndonesiaIrelandIsraelItalyJapanKazakhstanLatviaLithuaniaMacedoniaMalaysiaMexicoMoroccoNetherlandsNew ZealandNigerNorwayPanamaParaguayPeruPhilippinesPolandPortugalPuerto RicoRepublic of KoreaRomaniaRussian FederationSerbiaSingaporeSlovakiaSloveniaSouth AfricaSpainSudanSwedenSwitzerlandTaiwanTanzaniaThailandTunisiaTurkeyUkraineUnited KingdomUnited StatesUruguayVenezuelaVietnamZimbabweRegionAfricaSouth AmericaAsiaPacificEuropean UnionCaribbeanEuropeNorth AmericaCentral AmericaMiddle EastTrial ID2011-002908-332013-001944-762015-003213-182016-001058-162018-003465-332019-004613-142020-000820-202021-003815-252021-003993-302021-006556-14ACTRN12609001077257ACTRN12613000106730ACTRN12618000028202BVX20-CT1-001-10CTRI/2011/12/002232GHSG-OfatumumabISRCTN42054893JapicCTI-183914NCT00310037NCT00368082NCT00412594NCT00466531NCT00586391NCT00736320NCT00740805NCT00840853NCT00846742NCT00848328NCT00877214NCT00878254NCT00881920NCT00882895NCT00923013NCT00972478NCT01046825NCT01059786NCT01351896NCT01352520NCT01361711NCT01415752NCT01439750NCT01446133NCT01473628NCT01476410NCT01479842NCT01496976NCT01500733NCT01516580NCT01589302NCT01661881NCT01695941NCT01703949NCT01712490NCT01719835NCT01750567NCT01771107NCT01804686NCT01811368NCT01820910NCT01827605NCT01829568NCT01840566NCT01841723NCT01849263NCT01853631NCT01856192NCT01868451NCT01880567NCT01886872NCT01908777NCT01920932NCT01921790NCT01955499NCT01959698NCT01965977NCT01976520NCT02007044NCT02029443NCT02048813NCT02051257NCT02081937NCT02085655NCT02098512NCT02106988NCT02131584NCT02153580NCT02157324NCT02158091NCT02180711NCT02194751NCT02213913NCT02213926NCT02223208NCT02227199NCT02227251NCT02232516NCT02242097NCT02242942NCT02251548NCT02259556NCT02267915NCT02280993NCT02298257NCT02315768NCT02320383NCT02328014NCT02332668NCT02337829NCT02339922NCT02349698NCT02362035NCT02371161NCT02390869NCT02393157NCT02401503NCT02423837NCT02427451NCT02427620NCT02431403NCT02436707NCT02438501NCT02443077NCT02445404NCT02446457NCT02449252NCT02449278NCT02456350NCT02475681NCT02477696NCT02481310NCT02494700NCT02495415NCT02500407NCT02512497NCT02514083NCT02533700NCT02542124NCT02544425NCT02546440NCT02558816NCT02560441NCT02568267NCT02625480NCT02628405NCT02629809NCT02631044NCT02631239NCT02632396NCT02649387NCT02652910NCT02661503NCT02678299NCT02682641NCT02684292NCT02684708NCT02685670NCT02689869NCT02690545NCT02705508NCT02717611NCT02727803NCT02733380NCT02734771NCT02737046NCT02737085NCT02744612NCT02747732NCT02753062NCT02756897NCT02758717NCT02767674NCT02772198NCT02825836NCT02836639NCT02846584NCT02846623NCT02858258NCT02859402NCT02879526NCT02889523NCT02896582NCT02918747NCT02940301NCT02947347NCT02951728NCT02952508NCT02954445NCT02955628NCT02956382NCT02964858NCT02965092NCT02966756NCT02970318NCT02972840NCT02974647NCT02978625NCT02987244NCT02989532NCT02991638NCT03011814NCT03015896NCT03016871NCT03018626NCT03021057NCT03033914NCT03038672NCT03057795NCT03064867NCT03075696NCT03077828NCT03093116NCT03113500NCT03118180NCT03125642NCT03128879NCT03133221NCT03136146NCT03147885NCT03151876NCT03153202NCT03154918NCT03156101NCT03161223NCT03162536NCT03166878NCT03179917NCT03179930NCT03185494NCT03191773NCT03196830NCT03198026NCT03201471NCT03204188NCT03206671NCT03207178NCT03210662NCT03213652NCT03213678NCT03213704NCT03213977NCT03223610NCT03226249NCT03226301NCT03233347NCT03245905NCT03250962NCT03258047NCT03264131NCT03265106NCT03267433NCT03269669NCT03274492NCT03277729NCT03278782NCT03282396NCT03312205NCT03318835NCT03321890NCT03322865NCT03328078NCT03328273NCT03331198NCT03331341NCT03331731NCT03333486NCT03335098NCT03336333NCT03337919NCT03341520NCT03356054NCT03366324NCT03366350NCT03367143NCT03373019NCT03385226NCT03391726NCT03398161NCT03398967NCT03401853NCT03407144NCT03409432NCT03420183NCT03439501NCT03454945NCT03456466NCT03458260NCT03462719NCT03463057NCT03467867NCT03468153NCT03474133NCT03474744NCT03478514NCT03479918NCT03480334NCT03493217NCT03494179NCT03497533NCT03502629NCT03505554NCT03505944NCT03513562NCT03516617NCT03523975NCT03530683NCT03533283NCT03534323NCT03540849NCT03547700NCT03567876NCT03568461NCT03569696NCT03570892NCT03571568NCT03576378NCT03580928NCT03583424NCT03587844NCT03590574NCT03598179NCT03598608NCT03598998NCT03600363NCT03600441NCT03609593NCT03616782NCT03617432NCT03617666NCT03618550NCT03620578NCT03620903NCT03623087NCT03623373NCT03625037NCT03629873NCT03630042NCT03630731NCT03639181NCT03650933NCT03655483NCT03666000NCT03671018NCT03671850NCT03676504NCT03677154NCT03679455NCT03681561NCT03684889NCT03688451NCT03697356NCT03697408NCT03697512NCT03698994NCT03701282NCT03703050NCT03708003NCT03710772NCT03712202NCT03715309NCT03728972NCT03730740NCT03731234NCT03734198NCT03736616NCT03737981NCT03739619NCT03740529NCT03749018NCT03755804NCT03765177NCT03766763NCT03776279NCT03777085NCT03778619NCT03779113NCT03789240NCT03793140NCT03800706NCT03824483NCT03829254NCT03836261NCT03837873NCT03853616NCT03863184NCT03868722NCT03872180NCT03888105NCT03891355NCT03902184NCT03907488NCT03922724NCT03929107NCT03930953NCT03932331NCT03934567NCT03936153NCT03939026NCT03939182NCT03943901NCT03946878NCT03949062NCT03960840NCT03961672NCT03964090NCT03980002NCT03980171NCT03986034NCT03995147NCT04002297NCT04002947NCT04004572NCT04008706NCT04014205NCT04021992NCT04024696NCT04025593NCT04033302NCT04044222NCT04047797NCT04049513NCT04052659NCT04054167NCT04058470NCT04059081NCT04061512NCT04061772NCT04062448NCT04067037NCT04068597NCT04075292NCT04077723NCT04082936NCT04083495NCT04089215NCT04094311NCT04096690NCT04104776NCT04110301NCT04113226NCT04115631NCT04116437NCT04127227NCT04128072NCT04163302NCT04164368NCT04169737NCT04172246NCT04186520NCT04189757NCT04195555NCT04205409NCT04206943NCT04212013NCT04214626NCT04224493NCT04230304NCT04231370NCT04231448NCT04233294NCT04234061NCT04239170NCT04245839NCT04246086NCT04246359NCT04251065NCT04256018NCT04257578NCT04263480NCT04263584NCT04268706NCT04269902NCT04271410NCT04271800NCT04279379NCT04284774NCT04285567NCT04296786NCT04306887NCT04320888NCT04323657NCT04324879NCT04329130NCT04329728NCT04331119NCT04332822NCT04334174NCT04337606NCT04342936NCT04365036NCT04370405NCT04378647NCT04384484NCT04390737NCT04398953NCT04404088NCT04404283NCT04405375NCT04408638NCT04414163NCT04416451NCT04416984NCT04417166NCT04419519NCT04425824NCT04429438NCT04431089NCT04433156NCT04440059NCT04440436NCT04442022NCT04447768NCT04450173NCT04458610NCT04460248NCT04463953NCT04464200NCT04476459NCT04477486NCT04479267NCT04480099NCT04480125NCT04484012NCT04484506NCT04486391NCT04491370NCT04494503NCT04501939NCT04502394NCT04505254NCT04509700NCT04510610NCT04510636NCT04512534NCT04514081NCT04515238NCT04523428NCT04529772NCT04531046NCT04533581NCT04539444NCT04542824NCT04544592NCT04546620NCT04553393NCT04560322NCT04561206NCT04566887NCT04569032NCT04571138NCT04572763NCT04578613NCT04586478NCT04587687NCT04588922NCT04594798NCT04599556NCT04601831NCT04602065NCT04604067NCT04608318NCT04610970NCT04622579NCT04623541NCT04624633NCT04624958NCT04626791NCT04628494NCT04638790NCT04639362NCT04646395NCT04648475NCT04649983NCT04653649NCT04657094NCT04657302NCT04661007NCT04661020NCT04661943NCT04662255NCT04663347NCT04665765NCT04666038NCT04668365NCT04669171NCT04673617NCT04676360NCT04680052NCT04685616NCT04690192NCT04697940NCT04703192NCT04703686NCT04705129NCT04707079NCT04712097NCT04715217NCT04718883NCT04722172NCT04723914NCT04728893NCT04736914NCT04745234NCT04747236NCT04752826NCT04754035NCT04756726NCT04758975NCT04763083NCT04763616NCT04765111NCT04771507NCT04782193NCT04787263NCT04789434NCT04792489NCT04792502NCT04796857NCT04799275NCT04802590NCT04803201NCT04824092NCT04824794NCT04827862NCT04833114NCT04834024NCT04835870NCT04836507NCT04837859NCT04838652NCT04840602NCT04842487NCT04842877NCT04843267NCT04844528NCT04844866NCT04849351NCT04849416NCT04851119NCT04855253NCT04855695NCT04866654NCT04870944NCT04871607NCT04875195NCT04880434NCT04880746NCT04881838NCT04883437NCT04883749NCT04887259NCT04889716NCT04895436NCT04897477NCT04908228NCT04914741NCT04917250NCT04920617NCT04922567NCT04923048NCT04925609NCT04930653NCT04938232NCT04941716NCT04948788NCT04960618NCT04962126NCT04963946NCT04965493NCT04970901NCT04974216NCT04978584NCT04980222NCT04981899NCT04984837NCT04989621NCT04989803NCT04998669NCT05006716NCT05018520NCT05020015NCT05020392NCT05023980NCT05025423NCT05025800NCT05039073NCT05040906NCT05045664NCT05049473NCT05050630NCT05051891NCT05053971NCT05057494NCT05058404NCT05059912NCT05068440NCT05069051NCT05073250NCT05075460NCT05076097NCT05083208NCT05091424NCT05092451NCT05097443NCT05100862NCT05105841NCT05137886NCT05139017NCT05143112NCT05144841NCT05147467NCT05149170NCT05164770NCT05168930NCT05169489NCT05169658NCT05171647NCT05179733NCT05180097NCT05182957NCT05186012NCT05189093NCT05189197NCT05192486NCT05197192NCT05200312NCT05201248NCT05202782NCT05206357NCT05207670NCT05209308NCT05209620NCT05210868NCT05214183NCT05216835NCT05221645NCT05222555NCT05234684NCT05243693NCT05244642NCT05245656NCT05249959NCT05253118NCT05253495NCT05254743NCT05254899NCT05255601NCT05256641NCT05257018NCT05260957NCT05263583NCT05265975NCT05274997NCT05281809NCT05283720NCT05284825NCT05290090NCT05290337NCT05294731NCT05296070NCT05300282NCT05312476NCT05313243NCT05317936NCT05320081NCT05320640NCT05322330NCT05322733NCT05326243NCT05335018NCT05336812NCT05338931NCT05346809NCT05348213NCT05351346NCT05351593NCT05355051NCT05357794NCT05358379NCT05367856NCT05370547NCT05371054NCT05371093NCT05387616NCT05388006NCT05389293NCT05392257NCT05398224NCT05400876NCT05403450NCT05404945NCT05406401NCT05409066NCT05410418NCT05422066NCT05428670NCT05429268NCT05436223NCT05441761NCT05442515NCT05451810NCT05453396NCT05455697NCT05458297NCT05459571NCT05463263NCT05464433NCT05464719NCT05466318NCT05471843NCT05472610NCT05475925NCT05477264NCT05478512NCT05479994NCT05485753NCT05487170NCT05495100NCT05498220NCT05498259NCT05502250NCT05504603NCT05507541NCT05508867NCT05510219NCT05527912NCT05529069NCT05533775NCT05536349NCT05543070NCT05551936NCT05552937NCT05554939NCT05559008NCT05563844NCT05565417NCT05572983NCT05577364NCT05583149NCT05590221NCT05595447NCT05600686NCT05605899NCT05607420NCT05615636NCT05623982NCT05624554NCT05626322NCT05627856NCT05631912NCT05633615NCT05635162NCT05641428NCT05643742NCT05648019NCT05650723NCT05658562NCT05660967NCT05660993NCT05672251NCT05673785NCT05675410NCT05675813NCT05677919NCT05680558NCT05681195NCT05683171NCT05698147NCT05702853NCT05716087NCT05718869NCT05723055NCT05734495NCT05735834NCT05744037NCT05751798NCT05755828NCT05757219NCT05757466NCT05768529NCT05770037NCT05772624NCT05783596NCT05783609NCT05788081NCT05791409NCT05798156NCT05800366NCT05800977NCT05805943NCT05806099NCT05820841NCT05821088NCT05822050NCT05823701NCT05826535NCT05833724NCT05833763NCT05833893NCT05833984NCT05842707NCT05846750NCT05848765NCT05849857NCT05852717NCT05861050NCT05864742NCT05868395NCT05869279NCT05872854NCT05875428NCT05879458NCT05883449NCT05886036NCT05888493NCT05890352NCT05891821NCT05896046NCT05896163NCT05896813NCT05900765NCT05908409NCT05910801NCT05922904NCT05926427NCT05929222NCT05929612NCT05931263NCT05932173NCT05933967NCT05934513NCT05940051NCT05940064NCT05941156NCT05944978NCT05947851NCT05948033NCT05949931NCT05949944NCT05950165NCT05951959NCT05952024NCT05952037NCT05956041NCT05959694NCT05963074NCT05972720NCT05974085NCT05976763NCT05976997NCT05977673NCT05978739NCT05991388NCT05991973NCT05992597NCT05994235NCT06005870NCT06006117NCT06014073NCT06021678NCT06029309NCT06033820NCT06035497NCT06037239NCT06043323NCT06045247NCT06045910NCT06047080NCT06054776NCT06066203NCT06071871NCT06072131NCT06073821NCT06074107NCT06082102NCT06083701NCT06084936NCT06086197NCT06088654NCT06090539NCT06090864NCT06091254NCT06091865NCT06093841NCT06097364NCT06101381NCT06104553NCT06104566NCT06104592NCT06106841NCT06108232NCT06112847NCT06119685NCT06122389NCT06132737NCT06136351NCT06136559NCT06137144NCT06149169NCT06149286NCT06151080NCT06151106NCT06158386NCT06158399NCT06160843NCT06164275NCT06170489NCT06173999NCT06176729NCT06191744NCT06201507NCT06206174NCT06213311NCT06228963NCT06230224NCT06238648NCT06242834NCT06244368NCT06249191NCT06252675NCT06253663NCT06263491NCT06271057NCT06284122NCT06287398NCT06290817NCT06300528NCT06314334NCT06319456NCT06321289NCT06323525NCT06333262NCT06337318NCT06341556NCT06343311NCT06350318NCT06356129NCT06363994NCT06364423NCT06365671NCT06375733NCT06376721NCT06377540NCT06377566NCT06378138NCT06378190NCT06381830NCT06386315NCT06390956NCT06395103NCT06406556NCT06414148NCT06415708NCT06421948NCT06425302NCT06428019NCT06433362NCT06442475NCT06453044NCT06454968NCT06458439NCT06462248NCT06464185NCT06466122NCT06470451NCT06471738NCT06479356NCT06482684NCT06484920NCT06485219NCT06486051NCT06489808NCT06492304NCT06492629NCT06496308NCT06500273NCT06503094NCT06503263NCT06503276NCT06504199NCT06504394NCT06504940NCT06508658NCT06510361NCT06511869NCT06511895NCT06513234NCT06517511NCT06519526NCT06521255NCT06522386NCT06522555NCT06524375NCT06526793NCT06530511NCT06530550NCT06534060NCT06534437NCT06539182NCT06539195NCT06542250NCT06544785NCT06549595NCT06550336NCT06552559NCT06553352NCT06553872NCT06554600NCT06558513NCT06558604NCT06559553NCT06561048NCT06561425NCT06563245NCT06563505NCT06563596NCT06564038NCT06566586NCT06566807NCT06569485NCT06569680NCT06570447NCT06572618NCT06575686NCT06583083NCT06583837NCT06588478NCT06589089NCT06592170NCT06594640NCT06601504NCT06624085NCT06630091NCT06634589NCT06637501NCT06642792NCT06647732NCT06647940NCT06651853NCT06674096NCT06682130NCT06683885NCT06695013NCT06697184NCT06698003NCT06698484NCT06704555NCT06705530NCT06716658NCT06717347NCT06733051NCT06735495NCT06739265NCT06742996NCT06743945NCT06745076NCT06756308NCT06757647NCT06758037NCT06760156NCT06761677NCT06764017NCT06765317NCT06792253NCT06806033NCT06812858NCT06824883NCT06826118NCT06834529NCT06848569NCT06855823NCT06876688PhaseIIIIIIStatusActive, not recruitingRecruitingTherapy or DrugtherapyTradeNames (Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array, Array)Therapy or DrugABRABVDABVD-RAcalabrutinibAcalabrutinib-VenetoclaxAlectinibAlemtuzumabAlemtuzumab-RituximabAspaMetDexAVD-AAvelumabAVEPCAVOBCHPBDRBEACOPPBEAMBelinostatBendamustineBendamustine-OfatumumabBendamustine-RituximabBexarotenebleomycinBlinatumomabBortezomibBortezomib-DexamethasoneBortezomib-RituximabBrentuximab VedotinBrentuximab-BendamustineBrentuximab-NivolumabBRIBuparlisibBVRBVR2CamrelizumabCAP-VcRCAR NK ImmunotherapyCAR T Axicabtagene CiloleucelCAR T Brexucabtagene AutoleucelCAR T ImmunotherapyCAR T Lisocabtagene MaraleucelCAR T Relmacabtagene AutoleucelCAR T Talicabtagene AutoleucelCAR T TisagenlecleucelCAR T Varnimcabtagene AutoleucelcarboplatinCarfilzomibcarmustineCEOP-RChlorambucilChlorambucil-RituximabCHOEPCHOEP-RCHOPCHOP-OCHOP-RCHOP-R2CHOP-RICHOP-ROCHOP-RTCHOP-ScisplatinCladribineCladribine-RituximabCODOX-MCODOX-MRCODOX-MR/IVACCopanlisibCopanlisib-RituximabCOPPCRDCrizotinibCVPCVP-OCVP-RCyclophosphamidecytarabinecytarablinedacarbazineDBRDDGPDenileukin DiftitoxdexamethasoneDHAODHAPDHAP-RDICEDICE-Rdoxorubicindoxorubicin and dexamethasone alternating with high dose methotrexate and cytarabineDRCDRC-BortezomibDuvelisibDuvelisib-RituximabDVICEntinostatEntospletinibEnzastaurinEpcoritamabepirubicinEPOCHEPOCH-RER-CHOPER2ESHAPESHAP-RetoposideEverolimusFCMFCMRFCOFCRFludarabineFludarabine-CyclophosphamideFludarabine-RituximabFMDFMRFNDRForodesineGCDGDPGDPRGELOXgemcitabineGemOXGemOX-PGemOX-RGemOX-RPVGIVeGlofit-GemOXGlofitamabGolcadomideGolidocitinibGPV-R-CHPGVDHDMPHDMP-AHDMPRHigh-dose methylprednisoloneHyperCVADHyperCVAD-RHypericinIBRIbritumomab TiuxetanIbritumomab-RituximabIbrutinibIbrutinib-ObinutuzumabIbrutinib-RituximabIbrutinib-UblituximabICEICE-RIdelalisibIdelalisib-ObinutuzumabIdelalisib-OfatumumabIdelalisib-RituximabifosfamideIGEVInterferon-alphaintrathecal methotrexate cytarabineIR2ITIVAC (ara-c)IVAC-RIVE-RL-asparaginaseLenalidomideLenalidomide Maintenance Lenalidomide-RituximabLiposomal DoxorubicinLoncastuximab TesirineLoncastuximab-RituximabMACOP-BMCPMCP-RMechlorethamineMEDAmelphalanmesnaMethotrexatemethotrexate (high dose)MethoxypsoralenmethylprednisoloneMINEMINE-RmitoxantroneMogamulizumabMOPPMosunetuzumabMosunetuzumab-LenalidomideMosunetuzumab-PolatuzumabMoxetumomab pasudotoxNemtabrutinibNemtabrutinib-Venetoclaxnitrogen mustardNivolumabNORDICObinutuzumabObinutuzumab MaintenanceObinutuzumab-AcalabrutinibObinutuzumab-BendamustineObinutuzumab-ChlorambucilObinutuzumab-LenalidomideObinutuzumab-VenetoclaxOdronextamabOdronextamab-LenalidomideOdronextamab-RituximabOFAROfatumumabOfatumumab MaintenanceOfatumumab-ChlorambucilOrelabrutinibOtlertuzumaboxaliplatinPanobinostatPASP-GemOXPCRPCR2Pegaspargasepegaspargase (or L-asparaginase)PembrolizumabPenpulimabPentostatinPirtobrutinibPixantronePixantrone-RituximabPola-R-CHPPolatuzumab VedotinPralatrexateprednisoloneprednisoneprocarbazinePVBRPVRR-ACVBPR-BACResminostatRipertamabrituixmabRituximabrituximab and dexamethasone alternating with high dose methotrexate and cytarabineRituximab Biosimilar DRL_RIRituximab Biosimilar H02Rituximab Biosimilar HalpryzaRituximab Biosimilar NovexRituximab Biosimilar RiabniRituximab Biosimilar RixathonRituximab Biosimilar RTXM83Rituximab Biosimilar RuxienceRituximab Biosimilar TQB2303Rituximab Biosimilar TruximaRituximab MaintenanceRomidepsinSelinexorSIMPLESintilimabSMILESonrotoclaxSonrotoclax-ZanubrutinibSpebrutinibStanford VStem Cell TransplantSugemalimabTafasitamabTafasitamab-LenalidomideTazemetostatTemozolomideTemsirolimusThalidomideThalidomide-RituximabTirabrutinibTislelizumabTLRTopical CorticosteroidsToripalimabTotal skin electron beam therapyTR2TSEBTTucidinostatUblituximabUblituximab-UmbralisibUmbralisibUVA PhototherapyVaccine TherapyValemetostat TosylateVemurafenibVenetoclaxVenetoclax-IbrutinibVenetoclax-RituximabVIM-DvinblastinevincristinevindesinevinorelbineVIPDVorinostatZandelisibZandelisib-RituximabZanubrutinibZanubrutinib-ObinutuzumabZanubrutinib-RituximabZilovertamab VedotinZimberelimabZR2Zuberitamab Results () Website Content () Clinical Trials () Treatments () Resource Library ()